Literature DB >> 18197126

Characteristics of the env genes of HIV type 1 quasispecies in long-term nonprogressors with broadly neutralizing antibodies.

Martine Braibant1, Henri Agut, Christine Rouzioux, Dominique Costagliola, Brigitte Autran, Francis Barin.   

Abstract

Primary isolates of different subtypes of HIV-1 can be neutralized in vitro by the broadly neutralizing antibodies (NAbs) found in the sera of a small number of HIV-1-infected patients. This broad response is most frequent in long-term nonprogressors (LTNPs). We investigated whether the presence of NAbs in the sera of some LTNPs was associated with particular properties of the envelope glycoproteins of the variants found in these patients. Toward that aim, 147 env gene fragments (encoding almost the entire gp120) amplified from the proviral DNA of 5 LTNPs who developed broadly NAbs (NAb+) and of 4 LTNPs who did not develop such broadly NAbs (NAb-) were cloned, sequenced, and compared. We found that the development of broadly NAbs was associated with high viral loads, greater diversity in the gp120 of the viruses infecting these patients, and longer V1 sequences and additional N-gly sites in V1. In addition, a higher proportion of defective clones was found among the env genes of NAb- patients (25% to 93%)-particularly those with lower viral loads and low levels of env diversity-than among those of NAb+ patients (7% to 19%).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18197126     DOI: 10.1097/QAI.0b013e318162cac2

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  9 in total

1.  The V1V2 domain and an N-linked glycosylation site in the V3 loop of the HIV-1 envelope glycoprotein modulate neutralization sensitivity to the human broadly neutralizing antibody 2G12.

Authors:  Antoine Chaillon; Martine Braibant; Thierry Moreau; Suzie Thenin; Alain Moreau; Brigitte Autran; Francis Barin
Journal:  J Virol       Date:  2011-01-19       Impact factor: 5.103

2.  Coreceptor usage, diversity, and divergence in drug-naive and drug-exposed individuals from Malawi, infected with HIV-1 subtype C for more than 20 years.

Authors:  Ishla Seager; Simon A Travers; Michael D Leeson; Amelia C Crampin; Neil French; Judith R Glynn; Grace P McCormack
Journal:  AIDS Res Hum Retroviruses       Date:  2014-07-29       Impact factor: 2.205

3.  Autologous neutralizing antibodies to the transmitted/founder viruses emerge late after simian immunodeficiency virus SIVmac251 infection of rhesus monkeys.

Authors:  Wendy W Yeh; Ishita Rahman; Peter Hraber; Rory T Coffey; Daiva Nevidomskyte; Ayush Giri; Mohammed Asmal; Svetlana Miljkovic; Marcus Daniels; James B Whitney; Brandon F Keele; Beatrice H Hahn; Bette T Korber; George M Shaw; Michael S Seaman; Norman L Letvin
Journal:  J Virol       Date:  2010-03-31       Impact factor: 5.103

4.  Multiplexed highly-accurate DNA sequencing of closely-related HIV-1 variants using continuous long reads from single molecule, real-time sequencing.

Authors:  Dario A Dilernia; Jung-Ting Chien; Daniela C Monaco; Michael P S Brown; Zachary Ende; Martin J Deymier; Ling Yue; Ellen E Paxinos; Susan Allen; Alfredo Tirado-Ramos; Eric Hunter
Journal:  Nucleic Acids Res       Date:  2015-06-22       Impact factor: 16.971

5.  Characterization of circulating HIV type 1 env genes in plasma of two antiretroviral-naive slow progressing patients with broad neutralizing antibody response with evidence of recombination.

Authors:  Sampurna Mukhopadhyay; Rajesh Ringe; Ajit Patil; Ramesh Paranjape; Jayanta Bhattacharya
Journal:  AIDS Res Hum Retroviruses       Date:  2011-11-07       Impact factor: 2.205

6.  HIV-Specific B Cell Frequency Correlates with Neutralization Breadth in Patients Naturally Controlling HIV-Infection.

Authors:  Angeline Rouers; Jéromine Klingler; Bin Su; Assia Samri; Géraldine Laumond; Sophie Even; Véronique Avettand-Fenoel; Clemence Richetta; Nicodème Paul; Faroudy Boufassa; Laurent Hocqueloux; Hugo Mouquet; Christine Rouzioux; Olivier Lambotte; Brigitte Autran; Stéphanie Graff-Dubois; Christiane Moog; Arnaud Moris
Journal:  EBioMedicine       Date:  2017-05-31       Impact factor: 8.143

Review 7.  Impact of HIV-1 Diversity on Its Sensitivity to Neutralization.

Authors:  Karl Stefic; Mélanie Bouvin-Pley; Martine Braibant; Francis Barin
Journal:  Vaccines (Basel)       Date:  2019-07-25

8.  Human immunodeficiency virus type-1 (HIV-1) continues to evolve in presence of broadly neutralizing antibodies more than ten years after infection.

Authors:  Antoine Chaillon; Martine Braibant; Stéphane Hué; Samia Bencharif; David Enard; Alain Moreau; Assia Samri; Henri Agut; Francis Barin
Journal:  PLoS One       Date:  2012-08-30       Impact factor: 3.240

9.  Common evolutionary features of the envelope glycoprotein of HIV-1 in patients belonging to a transmission chain.

Authors:  Maxime Beretta; Julie Migraine; Alain Moreau; Asma Essat; Cécile Goujard; Marie-Laure Chaix; Aurélie Drouin; Mélanie Bouvin-Pley; Laurence Meyer; Francis Barin; Martine Braibant
Journal:  Sci Rep       Date:  2020-10-07       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.